Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Tracy L. Young‐Pearse, Hyo Lee, Yi‐Chen Hsieh, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 6, pp. 426-444
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment
Eric B. Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 16
A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 8
Microglial Responses to Alzheimer's Disease Pathology: Insights From “Omics” Studies
Aquene N. Reid, Suman Jayadev, Katherine E. Prater
Glia (2025) Vol. 73, Iss. 3, pp. 519-538
Closed Access | Times Cited: 1
Contributions of Genetic Variation in Astrocytes to Cell and Molecular Mechanisms of Risk and Resilience to Late‐Onset Alzheimer's Disease
Hyo Lee, Richard V. Pearse, Alexandra M. Lish, et al.
Glia (2025)
Open Access | Times Cited: 1
Once upon a time, the Amyloid Cascade Hypothesis
Alberto Granzotto, Stefano L. Sensi
Ageing Research Reviews (2023) Vol. 93, pp. 102161-102161
Open Access | Times Cited: 20
Person‐specific differences in ubiquitin‐proteasome mediated proteostasis in human neurons
Yi‐Chen Hsieh, Zachary M. Augur, Mason Arbery, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2952-2967
Open Access | Times Cited: 7
The growth rate of senile plaques is determined by the competition between the rate of deposition of free Aβ aggregates into plaques and the autocatalytic production of free Aβ aggregates
A. V. Kuznetsov
Journal of Theoretical Biology (2024) Vol. 593, pp. 111900-111900
Open Access | Times Cited: 7
Co‐Assembled Nanoparticles toward Multi‐Target Combinational Therapy of Alzheimer's Disease by Making Full Use of Molecular Recognition and Self‐Assembly
Wen‐Bo Li, Linlin Xu, Si‐Lei Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 28
Closed Access | Times Cited: 6
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Inhibition of BACE1 affected both its Aβ producing and degrading activities and increased Aβ42 and Aβ40 levels at high-level BACE1 expression
Irem Ulku, Rocher Leung, Fritz Herre, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107510-107510
Open Access | Times Cited: 5
Single-Molecule Characterization of Heterogeneous Oligomer Formation during Co-Aggregation of 40- and 42-Residue Amyloid-β
Fanjie Meng, Jae-Yeol Kim, John M. Louis, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 35, pp. 24426-24439
Closed Access | Times Cited: 4
Discovery of Isobavachin, a natural flavonoid, as an Apolipo-protein E4 (ApoE4) structure corrector for Alzheimer’s disease
Sachin Patil, Bella R. Kuehn, Christina McCullough, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Critical role of Oas1g and STAT1 pathways in neuroinflammation: insights for Alzheimer’s disease therapeutics
Zhixin Xie, Linxi Li, Weizhong Hou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Discovery of Isobavachin, a Natural Flavonoid, as an Apolipoprotein E4 (ApoE4) Structure Corrector for Alzheimer’s Disease
Sachin Patil, Bella R. Kuehn, Christina McCullough, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 940-940
Open Access
Decoding the Nectin Interactome: Implications for Brain Development, Plasticity, and Neurological Disorders
Shreyash Santosh Yadav, Krishnamoorthy Srinivasan, Shyam Sunder Sharma, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Improving effects of melatonin on memory and synaptic potentiation in a mouse model of Alzheimer’s-like disease: the involvement of glutamate homeostasis and mGluRs receptors
Narjes Khatoun Shabani Sadr, Fatemeh Bakhtiarzadeh, Koorosh Shahpasand, et al.
Behavioral and Brain Functions (2025) Vol. 21, Iss. 1
Open Access
Knowing the enemy: strategic targeting of complement to treat Alzheimer disease
Andrea J. Tenner, Tiffany J. Petrisko
Nature Reviews Neurology (2025)
Closed Access
Cannabinerol Restores mRNA Splicing Defects Induced by β-Amyloid in an In Vitro Model of Alzheimer’s Disease: A Transcriptomic Study
Maria Lui, Stefano Salamone, Federica Pollastro, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3113-3113
Open Access
Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?
Lou Fourrière, Paul A. Gleeson
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Neurologically altered brain activity may not look like aged brain activity: Implications for brain-age modeling and biomarker strategies
Lukas Gemein, Sinead Gaubert, Claire Paquet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by amyloid‐β (Aβ) oligomers
Luan Pereira Diniz, Juliana Morgado, Ana Paula Bérgamo Araújo, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 20, pp. 4028-4049
Closed Access | Times Cited: 3
The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence
Paul Aisen, Randall J. Bateman, Damian C. Crowther, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 3
Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review
Anna Maggiore, Valentina Latina, Maria D’Erme, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102578-102578
Open Access | Times Cited: 3
Function and mechanism of lysine crotonylation in health and disease
Lianjie Hou, Chen Yao, Qing Zhong, et al.
QJM (2024) Vol. 117, Iss. 10, pp. 695-708
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top